39.00p+0.00 (+0.00%)09 Apr 2021, 15:41
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Advanced Oncotherapy PLC Fundamentals

Company NameAdvanced Oncotherapy PLCLast Updated2021-04-09
IndustryMedical DevicesSectorHealthcare
Shares in Issue349.402 mMarket Cap£136.27 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.10EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.3876Debt Equity Ratio0.7184
Asset Equity Ratio2.4023Cash Equity Ratio0.1159
Quick Ratio0.3883Current Ratio1.47
Price To Book Value2.7488ROCE0

Advanced Oncotherapy PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Advanced Oncotherapy PLC Company Financials

Assets20192018
Tangible Assets£38.53 m£4.09 m
Intangible Assets£49.18 m£40.17 m
Investments00
Total Fixed Assets£88.63 m£45.77 m
Stocks£15.05 m£10.01 m
Debtors00
Cash & Equivalents£2.74 m£1.01 m
Other Assets00
Total Assets£110.82 m£59.45 m
Liabilities20192018
Creditors within 1 year£6.48 m£8.95 m
Creditors after 1 year£61.41 m£16.50 m
Other Liabilities00
Total Liabilities£67.89 m£25.45 m
Net assets£42.94 m£34.00 m
Equity20192018
Called up share capital£61.11 m£42.39 m
Share Premium£60.45 m£50.72 m
Profit / Loss-£21.88 m-£21.91 m
Other Equity£42.94 m£34.00 m
Preference & Minorities00
Total Capital Employed£42.94 m£34.00 m
Ratios20192018
Debt Ratio£0.510
Debt-to-Equity£1.050
Assets / Equity2.40232.4023
Cash / Equity0.11590.1159
EPS-£0.10-£0.14
Cash Flow20192018
Cash from operating activities-£23.55 m-£1.66 m
Cashflow before financing£13.90 m£12.99 m
Increase in Cash£2.23 m£910,675.00
Income20192018
Turnover00
Cost of sales0£1.91 m
Gross Profit0-£1.91 m
Operating Profit-£20.66 m-£21.85 m
Pre-Tax profit-£21.88 m-£21.91 m

Advanced Oncotherapy PLC Company Background

SectorHealthcare
ActivitiesAdvanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing in curing critical unmet conditions. The company's only business segments being Proton Therapy.
Latest Interim Date29 Sep 2020
Latest Fiscal Year End Date29 Jun 2020

Advanced Oncotherapy PLC Directors

AppointedNamePosition
2018-07-02Dr. Euan Stuart Thomson PhDNon-Executive Director,
2013-07-03Mr Philip Keith Charles Gibbs
2013-06-28Mr Paul Quentin Cullum Stacey
2020-10-05Dr. Michael Jeffrey SinclairChairman
2011-12-30Mr Stephen Kenneth WildenExecutive Director,Finance Director and Company Secretary
2016-10-25Lord David Evans of WatfordDeputy Chairman
2018-06-28Mr. Timothy Andrew Lebus Non-Executive Director,
2020-10-30Dr. Enrico Cipro VanniDirector
2013-08-30Mr. Trevor Edward Brown
2020-10-30Mr. Michael BradfieldDirector
2020-07-29Mr. Gabriel UrwitzDirector
2020-10-30Dr. Piers Nicholas Plowman Director
2018-07-02Professor Christopher NuttingDirector
2018-07-02Mr. Sanjeev PandyaDirector/Vice President, Divisional
2020-10-05Nicolas SerandourChief Executive Officer
2016-06-30Dr. Sanjeev KanoriaDirector
2020-10-05Professor Stephen Myers OBEDirector
2020-10-30Mr. Hans Henrik von CelsingDirector
2020-07-29Mr. Chunlin HanDirector

Advanced Oncotherapy PLC Contact Details

Company NameAdvanced Oncotherapy PLC
AddressLevel 17, Dashwood House, 69 Old Broad Street, London, EC2M 1QS
Telephone+44 2036178728
Websitehttp://www.avoplc.com

Advanced Oncotherapy PLC Advisors

SolicitorDechert LLP
Phone+44 2071847000
Fax+44 2071847001
StockbrokerStifel Nicolaus Europe Ltd
Phone+44 2077107600
Fax+44 2077107609
SolicitorFaegre Baker Daniels LLP
Phone+44 2074504500
Fax+44 2074504545
AuditorRPG Crouch Chapman LLP
Phone+44 2077820007
Fax+44 2077820939
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
StockbrokerStockdale Securities Ltd
Phone+44 2076016100
Nominated AdviserStockdale Securities Ltd
Phone+44 2076016100
SolicitorDavid Conway & Co
Phone020 7258 3000
Fax020 7258 3390
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342